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Administration of Iranian Propolis attenuates oxidative 
stress and blood glucose in type II diabetic patients: a 
randomized, double-blind, placebo-controlled, clinical trial 
 
 
Abstract 
Background: Hyperglycemia in diabetic people resulted in oxidative conditions. Propolis 
is the third most important component of bee products which has various functional 
properties such as anti-oxidant due to its components. The aim of this study was to 
evaluate the propolis effect on fructosamine level, the catalase activity, and the level of 
oxidized LDL changes in type 2 diabetic patients. 
Methods: In this double-blind, randomized controlled trial study, 62 type 2 diabetic 
patients, attending Endocrine clinic in Velayat Hospital (Qazvin, Iran) in 2017, were 
randomly assigned to one of intervention and placebo (n=31) groups. Participants in 
intervention group took propolis capsule (500 mg) 3 times a day and those in placebo 
group took placebo capsules for 8-week. Fructosamine level, catalase activity and the level 
of oxidized-LDL were measured at the baseline and at the end of the study. Statistical 
analysis was performed using SPSS software. 
Results: At the end of the study, significant differences were seen within groups and in-
between groups. In Propolis group compared to the placebo, fructosamine (p<0.05), and 
the level of oxidized LDL (p<0.05) decreased, and catalase activity (p<0.05) improved. 
However, there were no significant changes in the placebo group at the end of trial. 
Conclusion: Eight weeks intake of propolis as a supplement in type II diabetic patients 
could improve anti-oxidant defense and decline production of hyperglycemia induced 
products such as fructosamine. 
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Diabetes mellitus, an endocrine metabolic disease, is a leading global health 
emergency and is associated with serious complications contributing to high morbidity and 
mortality rates estimated to cost billion dollars per year. It was estimated that in 2015 415 
million adults were living with diabetes worldwide, which 90-95%  were living with type 2 
diabetes mellitus (T2DM) (1). T2DM considerably is attributed to macro and 
microvascular complications, and comorbidities such as cardiovascular disease; which 
many of are associated with poor glycemic control (2). Hyperglycemia increases the 
production of reactive oxygen species (ROS) and also diminishes antioxidative 
mechanisms by glycation of the scavenging enzymes (3). Accordingly, it is estimated that 
the down regulation of ROS generation may have an essential role in controlling diabetic 
complications (4). 
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Fortunately, the various antioxidant defense systems to 
remove ROS have been well built in the human body. In 
other words, various substances containing the non-
enzymatic chemicals such as superoxide dismutase (SOD), 
glutathione peroxidase (GPX), catalase (CAT), vitamin C 
and E, beta-carotene, and glutathione act as the antioxidant 
enzyme in the body (5, 6). Catalase, one of the enzymes of 
the biological antioxidative system, removes hydrogen 
peroxide, H2O2, by converting it to water and oxygen. 
H2O2, a most stable forms of ROS might be generated by 
both exogenous and endogenous factors (7). 
Glycation is identified as a detrimental phenomenon in 
diabetic complications and in association with oxidative 
stress seems to be detrimental too (8). One of the underlying 
results of hyperglycemia is the excessive non-enzymatic 
glycation of the two main proteins: hemoglobin and albumin, 
known as HbA1c and fructosamine (8, 9). Both fructosamine 
and HbA1c are used for assessment of glycemic control. 
However, long half-life of glycated hemoglobin (6–8 
weeks), reflects glycemic control over a longer period of 
time versus fructosamine with a shorter half-life (only 2–3 
weeks), has a greater sensitivity to the rapid glucose changes 
(10). Today there are varieties of natural products which 
used in treating a large array of systemic diseases. Propolis a 
non-toxic resinous natural substance was made by bees for 
building and preserving their hives, by killing pathogens, 
shielding the honeycomb from the rain. Also, propolis due to 
its adhesive feature prevents foreign guests entering the hive 
(11). The biological activity of propolis is mostly related to 
flavonoids and hydroxycinnamic acid contents (12). 
Research has shown that flavonoid contents of propolis are 
dependent on the environmental condition, the site of 
collection, the origin, and type of plant pollen and species of 
bees that produced it. Antimicrobial, anticancer, antifungal, 
antiviral and anti-inflammatory properties ascribe to propolis 
(12, 13). According to the studies that were conducted in 
diabetic models, propolis administration has potential to 
ameliorating antioxidant capacity, by increasing antioxidant 
enzyme level, and could reduce blood glucose levels which 
could alleviate diabetic symptoms and result in better 
diabetic control (14-16). Due to the high cost of prevention 
and treatment of this disorder, the aim of this study was to 
evaluate the effect of propolis supplementation on 
fructosamine level, the catalase activity, and the level of 
oxidized LDL changes to prove propolis beneficial effects as 
a supplement on diabetic condition. 
Methods 
Participants: This double-blind randomized controlled 
clinical trial was conducted in Velayat Hospital (Qazvin, 
Iran) on patients with type 2 diabetes. The inclusion criteria 
were willing to contribute, aged 30-55 years with a medium 
physical activity (according to a valid and reliable version of 
the International Physical Activity Questionnaire (IPAQ) in 
Iran (17)), that did not change their treatment methods and 
their medications at least in the last two months. Patients 
were excluded by each of the following conditions: insulin 
treatment, having diabetes over ten years, pregnancy and 
lactation, hospitalization during the study, patients with 
severe renal and hepatic disorders, any acute illness that may 
affect the study (cardiovascular, pulmonary, kidney, and 
cancer), change in dose of blood glucose lowering drugs, 
changes in diet or physical activity levels, dietary 
supplement consumption two month before, allergy, 
smoking or alcohol consumption and the  occurrence of any 
side effects due to the intervention. 
The protocol of this study was approved by the Ethics 
Committee of the Qazvin University of Medical Sciences, 
Qazvin, Iran, and was recorded in the Iranian Registry of 
Clinical Trials website with a code of 
IRCT2017041019669N4. 
Sample Size and setting: According to the GPx factor that 
was reported in Afsharpour et al.’s study (18), 22 persons 
were estimated in each group. If the mean and standard 
deviation of the GPx at the base and the end of intervention 
were 43±5.2 and 51±7.2 respectively, and by β = 0.2 and 
α=0.05 assumption in the sample size estimation formula 
mentioned below, 22 persons were calculated. By 
considering the probability of 35 percent sample size 
dropout, 30 persons were selected for each group.  
N= [(Z1-α/2 + Z1-β) 2 (SD12+SD22)] /∆2 
Study Design: Sixty-two patients (men & women) who 
referred, were matched by age, gender, and weight, and then 
randomly assigned to two groups. Windows based software 
which had been designed to use and allocate number by 
utilizing a randomized number table was used for number 
assignment in a random way to each subject. In this method, 
the investigator and all participants were blinded to 
treatment.  
The treatment group (n=31) received 1500 mg propolis 
(500 mg capsule 3 times a day) and the placebo group 
(n=31) received matching placebo for 60 days. The duration 
of this study was built on our previous study (18). 
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Each propolis capsule contained powdered propolis, 
which originated from Alamut, Qazvin. Propolis was 
powdered and encapsulated by a Traditional-Medicine 
researcher at the Azad University of Tabriz, Tabriz, Iran. 
Placebo capsules contained wheat flour. All capsules had an 
identical appearance with a specific identifier code in which 
the investigator and patients, both were blinded until the end 
of supplementation. The distribution was according to 
allocation codes after randomization. To ensure blindness, 
capsules allocation was performed by a trained investigator 
who did not involve in this trial. 
In a face to face interview, demographic data and food 
recall questionnaires for 3 non-sequential days were 
collected by a trained nutritionist. 
Patient’s weight in minimally clothed was measured with 
Seca scales and their height was measured in a standing 
position and without shoes with a fixed‐to‐wall tape meter. 
After that, BMI (body mass index) was calculated in 
kilograms per square meter. 
Ethical considerations: This study was registered at the 
Ethics Committee of Qazvin University of Medical Sciences 
that vouched for its ethical considerations 
Ir.qums.rec.1396.410. At the beginning of the study, the 
goals and method of the study were fully explained to the 
patients. They were assured that their medical history and 
identity would be confined and the possibility of stopping 
cooperation at any time as they wish. They volunteered and 
those who agreed and qualified completed a written 
informed consent. 
Laboratory analysis: Fasting blood samples were collected 
before and after supplementation. Hemoglobin tests were 
performed on the same day. Then with a refrigerated 
centrifuge, at 4° C and 3000 rpm, the plasma was separated 
and stored at -70° C for further tests. Fructosamine was 
assessed in the method of calorimetric enzymatic using 
commercial kits (Diazyme kit, USA). Measurement of 
catalase activity was performed by USA Cayman 
commercial kit. Measurements of oxidized LDL were 
performed using ELISA kit purchased from Mercodia 
Sweden. 
Statistical analysis: The data were analyzed using SPSS 20 
for Windows software. All data were presented as mean±SD 
and were checked for normality by the Kolmogorov–
Smirnov test. Due to the normal distribution of variables, the 
paired sample t-test and the independent sample t-test were 
applied to analyze differences in variables within and 
between groups, respectively. The p<0.05 was considered 
statistically significant. 
 
 
Results 
Seventy-two patients were enrolled in this study, 
however, only sixty-two were qualified for the intervention. 
Two patients from the propolis group and the placebo group 
dropped out because of personal reasons. The final analysis 
was done on the subjects who finished the study (figure1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart of patients' enrolment 
 
There were no statistical differences in baseline 
characteristics of participants between the two groups. The 
mean age of all participants was 50.43±7.27 years. All the 
characteristics data are listed in table1.  
 
Table 1. Demographic characteristics of participants at 
baseline 
Characteristics 
Propolis(n=30) 
Mean±SD 
Placebo(n=30) 
Mean±SD 
p-
value 
Age (year) 51.81 ± 6.35 49.05 ± 8.2 0.24 
Weight (kg) 
Baseline 68.2 ± 9.7 70.76 ±11.7 0.63 
End 68 ± 9.04 71.5 ±11.84 0.42 
BMI(kg/m2) 
Baseline 26.78 ± 3.01 26.74±3.7 0.81 
End 26.7 ± 2.8 27.01 ± 3.7 0.62 
Metformin dose 1518.17±329.2 1502.26±410.91 0.91 
Diabetes duration 
(year) 
5.47 ± 3.6 5.38 ± 3.1 0.9 
 
Propolis supplementation, compared to the placebo, 
significantly and statistically decreased the fructosamine 
(p<0.03), and the level of oxidized LDL (p<0.04), and 
increased the catalase activity (p<0.05). Within groups, 
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analysis indicated statistical decrease on the fructosamine 
and the level of oxidized LDL, and statistical increase 
significance in the catalase activity after intervention in the 
Propolis group (p<0.05). There were no significant statistical 
changes in the placebo group. No side effects of the 
treatment with Propolis were reported during the study. 
Statistical data are shown in table 2. 
 
Table 2. Effect of propolis on the level of fructosamine, 
catalase activity and oxidized-LDL in two groups 
Variables 
Mean±SD 
Propolis(n=30) 
Mean±SD 
Placebo(n=30) 
P1 
Fructosamine 
(μmol) 
Baseline 391.19±101.82 400.9±87 0.611 
End 336.477±97.21 402.43±103.75 0.019 
P2 0.023 0.847  
Catalase 
Activity 
(U/ml) 
Baseline 68.35±22.36 72.58±24.36 0.601 
End 83.06±27.37 70.78 ±23.05 0.041 
P2 0.031 0.759  
Oxidized 
LDL 
 (mU/l) 
Baseline 14.43±4.01 13.9±3.67 0.54 
End 9.71±3.24 12.94±3.09 0.031 
P2 0.004 0.428  
 
Discussions 
Insulin resistance or deficiency of insulin secretion in 
diabetic patients type 2 cause chronic hyperglycemia and 
impaired carbohydrates, lipids, and protein metabolism and 
ultimately promote the generation of reactive oxygen species 
and oxidative stress (19,20). Hyperglycemia has been seen as 
the leading cause of diabetic cardiomyopathy by activation 
of different mechanisms leading to oxidative stress (21). 
Several antioxidants including vitamins and supplements 
as well as flavonoid compounds have been investigated for 
DM oxidative stress treatment, which has demonstrated a 
beneficial effect in DM patients (22). For example, Jarouliya 
et al. demonstrated that Spirulina due to its antioxidant 
properties not only improved blood glucose levels, but also 
oxidative markers (23). Furthermore, ROS production in 
diabetes may activate the MAPK (mitogen-activated protein 
kinases) signaling cascade, the main component of the 
proapoptotic signaling pathway, induced by diabetes mellitus 
can have destructive effects on cellular function. Results in 
Kadry M. Sadek et al. study revealed that Spirulina has a 
significant impact on MAPK activity (24). The propolis 
chemical composition, depending on the plant species from 
which the bees collect the exudates is highly variable; 
therefore, geographic location is a major determinant. The 
most widely used propolis contains mainly phenolic: 
ﬂavonoids aglycone, aromatic acids, and their esters (25). 
The propolis biological action is taken from its active 
constituents including flavonoids with antioxidants (26). The 
present study investigated the effect of Iranian Propolis on 
fructosamine, the catalase activity and changes in oxidized 
LDL level in type II diabetes. 
Reports have demonstrated that concentrations of serum 
advanced glycation end-products (AGEs) elevate in healthy 
individuals with higher ages, and these were associated with 
elevated levels of oxidative stress and inflammation (27). 
Chronic hyperglycemia in uncontrolled diabetes increases 
AGE formation which will also lead to increased RAGE 
signaling (receptors for AGEs), oxidative stress and 
inflammation. Increased AGE may lead to oxidative stress 
and, vice versa (28, 29). 
Unfortunately, there is a point that oxidative stress is a 
key mechanism for albumin glycation in individuals without 
diabetes (30). Accumulating data has shown that serum 
fructosamine is prospectively associated with morbidity-
mortality risks of cardiovascular disease in both diabetic and 
non-diabetic patients (30, 31). Fuliang et al. demonstrated 
that fructosamine levels decreased in rats fed with ethanol 
extract of Propolis (EEP). They observed that EEP reduced 
plasma glucose levels, suppressed oxidative stress, and 
reduced oxidants in diabetic rats (32). Since this regent is the 
first product in the glycation procedure, it supports the 
observation of the antiglycation effect of EEP. Another 
recent study reported the chelating property of propolis can 
play an important role in the anti-glycation activity of 
propolis (33, 34). The small minority of studies investigated 
the effects of propolis on fructosamine and of these, there is 
no single study that has been done in human, however, our 
results in confirmation of animal studies, showed that 8-
week propolis supplementation led to lower fructosamine 
formation in diabetic people. 
It has been confirmed that the mitochondrial catalase 
overexpression can reduce the prevalence of arteriosclerosis 
and cataract in mice, and also protects against cardiovascular 
dysfunctions and injuries in human (35, 36). In our study, 
catalase activity remarkably was enhanced in the propolis 
group in comparison to baseline and the placebo group. This 
outcome is consistent with the properties that were attributed 
to the propolis chemical composition as well as studies on 
antioxidant capacity changes due to propolis consumption. 
At the end of a 18-week study, recruited T2DM patients who 
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were treated by Chinese propolis (900 mg/day) serum GSH, 
ﬂavonoids, and polyphenols signiﬁcantly increased, and 
serum lactate dehydrogenase activity was signiﬁcantly 
reduced, however, no signiﬁcant difference was found 
between the groups in serum glucose, glycosylated 
hemoglobin, insulin (16). Another study reported that the 
levels of glutathione peroxidase and catalase (antioxidant 
enzymes) increased in rats fed with EEP treated with sodium 
fluoride in comparison with the control group (37).  
Oxidative stress by excessive generation of prooxidant 
species, as well as deficiency of antioxidant defense 
mechanisms result in damage to different cellular 
components. The most susceptible targets of oxidation are 
lipids and plasma oxidized LDL (ox-LDL) playing a 
significant role in atherosclerosis development (38, 39). 
Several studies in adults demonstrated significant 
correlations between high circulating ox-LDL levels and 
CVDs, diabetes and metabolic syndrome prevalence (40). 
The powerful antioxidant potential of propolis is active 
against oxidative stress and may induce a positive effect on 
diabetic metabolic complications. Verónica Mujica et al. 
have shown that propolis leads to thiobarbituric acid reactive 
substances (TBARS) levels dwindling which are formed as a 
byproduct of lipid peroxidation and increase glutathione 
(GSH) levels, a powerful antioxidant that protects the 
important cellular components against free radicals. Results 
suggested that the inhibitory effect on lipid peroxidation of 
propolis reduces the production of oxyger free radicles and 
decrease oxidative stress (41). Another study reported that 
propolis supplementation for 12 weeks can result in 
glycemic and some lipid levels reduction in type 2 diabetes 
patients (42).  
Serum cholesterol, triglycerides, LDLc, VLDL, 
atherogenic and atherogenic parameters significantly 
declined and serum HDLc increaset in intoxicated male 
albino mice that were treated by aqueous extract of Libyan 
propolis. It can be concluded propolis had hypolipidemic and 
antiatherogenic effects in mice (43). Results of treatment of 
both types of propolis (Chinese and Brazilian) by 
Hongzhuan Xuan study significantly indicated increased cell 
viability and attenuated apoptosis rate. This study also 
showed that both types of Propolis inhibited the effect of ox-
LDL in human umbilical vein endothelial cells on ROS 
generation as well as the subsequent MMP collapse, and NF-
𝜅Bp65 activation (44). Similar to the articles listed above the 
final analysis of our data suggested that 8-weeks propolis 
treatment has the power to reduce ox-LDL in diabetic 
people. 
The results of the present study demonstrated that Iranian 
propolis treatment significantly diminished fructosamine and 
oxidized-LDL after 8-week supplementation and also 
catalase activity improved by supplementation in the 
propolis group. Nevertheless, due to budget limitations, we 
were not able to consider a larger sample size, different 
doses, longer duration, and considering other groups (such as 
an antioxidant group) to explain the clinical relevance of 
finding data. In conclusion, propolis has a potential to 
improve antioxidant capacity (catalase activity) and alleviate 
AGEs products and lipid oxidation in DM patients.  
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